Correlation Analysis of Interleukin-6 on Blood Glucose in Prediabetes and Normal Glycemic Status


  • Ratih Feraritra Danu Atmaja Medical Laboratory Technology Faculty, Health Polytechnic Ministry of Health Kendari, Indonesia.
  • Theosobia Grace Orno Medical Laboratory Technology Faculty, Health Polytechnic Ministry of Health Kendari, Indonesia.
  • Tuty Yuniarty Medical Laboratory Technology Faculty, Health Polytechnic Ministry of Health Kendari, Indonesia.
  • Handayani Malik Faculty of Medicine, Hasanuddin University Medical Research Center (HUMRC), Hasanuddin University, Indonesia. Faculty of Health Technology, Mega Rezky University, Indonesia.



Diabetes mellitus is a global health problem whose incidence rate continues to increase yearly. Most people with diabetes mellitus go through the prediabetes phase. Prediabetes is a condition where blood glucose levels are elevated but have not yet reached the criteria for diabetes mellitus. Low-grade chronic inflammation is one of the pathways known to interfere with insulin signalling that ultimately affects blood glucose levels. One of the most studied inflammatory pathways in the pathogenesis of diabetes mellitus is interleukin-6 (IL-6). This study aims to determine whether there were differences in IL-6 levels between groups of prediabetes subjects and normal subjects and to observe the correlation between IL-6 levels and blood glucose. This study is useful in providing additional scientific evidence on the development of diabetes mellitus, especially in blood glucose regulation through inflammatory pathways. The design of this study was analytic observational in 71 subjects with prediabetes or normal glycemic status. Prediabetes status was established based on fasting blood glucose levels and glucose levels 2 hours post oral glucose tolerance test. Subjects with fasting blood glucose levels> 125mg/ dl and who had a fever in the last week were excluded from the study. Interleukin 6 levels were measured based on the principle of enzyme-linked immunoassay. The correlation of interleukin 6 with glucose levels and other variables was analyzed using the spearmen test. The results showed that interleukin 6 levels did not differ between the prediabetes group and the normal group ((5.27 ± 2.55 pg/ml) vs (4.44 ± 2.46) respectively; (p=0.105)). There was no correlation between interleukin 6 level and fasting blood glucose level (r=0.014, p=0.908) and glucose level after the oral glucose tolerance test (r=-0.085, p=0.480). In this study, there was a significant correlation between body mass index with waist circumference (r=0.772, p=0.000) and glucose levels after the oral glucose tolerance test (r=0.240; p<0.001). Recommends the addition of anti-inflammatory cytokines and variable insulin to assess further the effect of the inflammatory process on the glucose metabolism of subjects in future studies.


Agarwal, A., Hegde, A., Yadav, C., Ahmad, A., Manjrekar, P. A., & Srikantiah, R. M. (2017). Association of Interleukin-6 and Myeloperoxidase with Insulin Resistance in Impaired Fasting Glucose Subjects. Indian Journal of Clinical Biochemistry, 32(1), 33–38.

Akbari, M., & Hassan-Zadeh, V. (2018a). Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes. Immunological Investigations, 47(7), 654–665.

Akbari, M., & Hassan-Zadeh, V. (2018b). IL-6 signalling pathways and the development of type 2 diabetes. Inflammopharmacology, 26(3), 685–698.

Akbari, M., & Hassan-Zadeh, V. (2018c). Hyperglycemia Affects the Expression of Inflammatory Genes in Peripheral Blood Mononuclear Cells of Patients with Type 2 Diabetes. Immunological Investigations, 47(7), 654–665.

Akour, A., Kasabri, V., Bulatova, N., Muhaissen, S. Al, Naffa, R., Fahmawi, H., Momani, M., Zayed, A., & Bustanji, Y. (2017). Association of oxytocin with glucose intolerance and inflammation biomarkers in metabolic syndrome patients with and without prediabetes. Review of Diabetic Studies, 14(4), 364–371.

Alberti, S. G., Zimmet, P., Shaw, J., & Grundy, S. M. (2006). The IDF consensus worldwide definition of metabolic syndrome. In International Diabetes Federation.

Almuraikhy, S., Kafienah, W., Bashah, M., Diboun, I., Jaganjac, M., Al-Khelaifi, F., Abdesselem, H., Mazloum, N. A., Alsayrafi, M., Mohamed-Ali, V., & Elrayess, M. A. (2016). Interleukin-6 induces impairment in human subcutaneous adipogenesis in obesity-associated insulin resistance. Diabetologia, 59(11), 2406–2416.

Alwash, S. M., McIntyre, H. D., & Mamun, A. (2021). The association of general obesity, central obesity and visceral body fat with the risk of gestational diabetes mellitus: Evidence from a systematic review and meta-analysis. Obesity Research & Clinical Practice, 15(5), 425–430.

American Diabetes Association. (2022). Classification and Diagnosis of Diabetes : Standards of Medical Care in Diabetes — 2022. Diabetes Care, 45(Suppl), 17–38.

Badan Penelitian dan Pengembangan Kesehatan Kemenkes RI. (2018). Laporan Nasional Riskesdas 2018. In Balitbangkes. Lembaga Penerbit Balitbangkes.

Butkowski, E. G., Brix, L. M., Kiat, H., Al-Aubaidy, H., & Jelinek, H. F. (2016). Diabetes, oxidative stress and cardiovascular risk. Basic Research Journal of Medicine and Clinical Sciences, February.

Cho, N. H., Ku, E. J., Jung, K. Y., Oh, T. J., Kwak, S. H., Moon, J. H., Park, K. S., Jang, H. C., Kim, Y. J., & Choi, S. H. (2020). Estimated Association Between Cytokines and the Progression to Diabetes: 10-year Follow-Up From a Community-Based Cohort. Journal of Clinical Endocrinology and Metabolism, 105(3), 381–389.

De Filippo, G., Rendina, D., Moccia, F., Rocco, V., & Campanozzi, A. (2014). Interleukin-6, soluble interleukin-6 receptor/interleukin-6 complex and insulin resistance in obese children and adolescents. Journal of Endocrinological Investigation, 1–5.

Enga, F. S. (2013). Pengaruh diet tinggi karbohidrat terhadap jumlah neutrofil dan interleukin 6 (IL-6) pada tikus wistar jantan. Widya Mandala Catholic University Surabaya.

Hossain, M., Faruque, M. O., Kabir, G., Hassan, N., Sikdar, D., Nahar, Q., & Ali, L. (2010). Association of serum TNF-α and IL-6 with insulin secretion and insulin resistance in IFG and IGT subjects in a Bangladeshi population. International Journal of Diabetes Mellitus, 2(3), 165–168.

Hu, H., Kawasaki, Y., Kuwahara, K., Nakagawa, T., Honda, T., Yamamoto, S., Eguchi, M., Kochi, T., Nishihara, A., Imai, T., Yamamoto, M., Okazaki, H., Miyamoto, T., Tomita, K., Uehara, A., Ogasawara, T., Sasaki, N., Hori, A., Nagahama, S., … Dohi, S. (2020). Trajectories of body mass index and waist circumference before the onset of diabetes among people with prediabetes. Clinical Nutrition (Edinburgh, Scotland), 39(9), 2881–2888.

Huang, K., Liang, Y., Ma, Y., Wu, J., Luo, H., & Yi, B. (2022). The Variation and Correlation of Serum Adiponectin, Nesfatin-1, IL-6, and TNF-α Levels in Prediabetes. Frontiers in Endocrinology, 13(March), 1–10.

Itoh, H., Ueda, M., Suzuki, M., & Kohmura-Kobayashi, Y. (2022). Developmental Origins of Metaflammation; A Bridge to the Future Between the DOHaD Theory and Evolutionary Biology. Frontiers in Endocrinology, 13(February), 1–7.

Kementrian Kesehatan Republik Indonesia. (2018). Hari Diabetes Sedunia Tahun 2018. Pusat Data Dan Informasi Kementrian Kesehatan RI, 1–8.

Lainampetch, J., Panprathip, P., Phosat, C., Chumpathat, N., Prangthip, P., Soonthornworasiri, N., Puduang, S., Wechjakwen, N., & Kwanbunjan, K. (2019). Association of Tumor Necrosis Factor Alpha, Interleukin 6, and C-Reactive Protein with the Risk of Developing Type 2 Diabetes: A Retrospective Cohort Study of Rural Thais. Journal of Diabetes Research, 2019, 9051929.

Lehrskov, L. L., & Christensen, R. H. (2019). The role of interleukin-6 in glucose homeostasis and lipid metabolism. Seminars in Immunopathology, 41(4), 491–499.

Li, X., Qiu, W., Li, N., Da, X., Ma, Q., Hou, Y., Wang, T., Song, M., & Chen, J. (2020). Susceptibility to Hyperglycemia in Rats With Stress-Induced Depressive-Like Behavior: Involvement of IL-6 Mediated Glucose Homeostasis Signaling. Frontiers in Psychiatry, 11(June), 1–13.

Long, M.-H., Zhang, C., Xu, D.-Q., Fu, W.-L., Gan, X.-D., Li, F., Wang, Q., Xia, W., & Xu, D.-G. (2020). PM(2.5) aggravates diabetes via the systemically activated IL-6-mediated STAT3/SOCS3 pathway in rats’ liver. Environmental Pollution (Barking, Essex : 1987), 256, 113342.

Lopez, Y. O. N., Garufi Gabriella, & Seyhan, A. A. (2017). Altered levels of circulating cytokines and microRNAs in lean and obese individuals with prediabetes and type 2 diabetes. Molecular BioSystems, 13(1), 106–121.

Nisr, R. B., Shah, D. S., Ganley, I. G., & Hundal, H. S. (2019). Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading. Cellular and Molecular Life Sciences, 76(24), 4887–4904.

Perkumpulan Endokriologi Indonesia. (2021). Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia. In PB Perkeni. PB Perkeni.

Persatuan Diabetes Indonesia, & Perkumpulan Endokriologi Indonesia. (2019). Pedoman pengolaan dan pencegahan prediabetes di Indonesia 2019. In Surabaya.

Phosat, C., Panprathip, P., Chumpathat, N., Prangthip, P., Chantratita, N., Soonthornworasiri, N., Puduang, S., & Kwanbunjan, K. (2017). Elevated C-reactive protein, interleukin 6, tumor necrosis factor alpha and glycemic load associated with type 2 diabetes mellitus in rural Thais: A cross-sectional study. BMC Endocrine Disorders, 17(1), 1–8.

Randeria, S. N., Thomson, G. J. A., Nell, T. A., Roberts, T., & Pretorius, E. (2019). Inflammatory cytokines in type 2 diabetes mellitus as facilitators of hypercoagulation and abnormal clot formation. Cardiovascular Diabetology, 1–15.

Saeedi, P., Petersohn, I., Salpea, P., Malanda, B., Karuranga, S., Unwin, N., Colagiuri, S., Guariguata, L., Motala, A. A., Ogurtsova, K., Shaw, J. E., Bright, D., & Williams, R. (2019). Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9(th) edition. Diabetes Research and Clinical Practice, 157, 107843.

Snehalatha, C., Satyavani, K., Sivasankari, S., Vijay, V., & Ramachandran, A. (2017). Insulin secretion and action in different stages of glucose tolerance in Asian Indians. Diabetic Medicine, 16(5), 408–414.

Valaiyapathi, B., Gower, B., & Ashraf, A. P. (2020). Pathophysiology of Type 2 Diabetes in Children and Adolescents. Current Diabetes Reviews, 16(3), 220–229.

Weaver, J. R., Odanga, J. J., Breathwaite, E. K., Treadwell, M. L., Murchinson, A. C., Walters, G., Fuentes, D. P., & Lee, J. B. (2021). An increase in inflammation and islet dysfunction is a feature of prediabetes. Diabetes/Metabolism Research and Reviews, 37(6), e3405.

World Health Organization. (2006). Definition and diagnosis of diabetes mellitus and intermediate hyperglicaemia: report of a WHO/IDF consultation. In World Health Organization. WHO press.

World Health Organization. (2016). Global Report on Diabetes. In WHO (Vol. 978).

World Health Organization. (2021). Diabetes - Fact Sheet.

Zhuravlyova, L., Sokolnikova, N., Filonenko, M., & Rogachova, T. (2019). Interleukin-1β and interleukin-6 - a new markers of metabolic disorders in diabetes mellitus type 2. Georgian medical news, 287, 82–87.




How to Cite

Danu Atmaja, R. F., Orno, T. G., Yuniarty, T., & Malik, H. (2023). Correlation Analysis of Interleukin-6 on Blood Glucose in Prediabetes and Normal Glycemic Status. Medical Laboratory Technology Journal, 9(1).